Waters Corporation (WAT)
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-05
$453.08-3.11%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-05
QuarterlyIQ Insights · WAT
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 10.0% |
| Our one-year growth estimate | diamond | 45.4% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 35.4 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 18 industry peers · Company calendar date is not available
WAT — President transition
Dated 2026-08-21
Senior Vice President — Robert L. Carpio III: The Senior Vice President of a specific division resigned to pursue other opportunities, representing a genuine executive departure but not necessarily a shock to the entire company's leadership.
Why it matters: Waters raised its full-year range twice. Results inside or above the new range would back that growth progress.
Supportive ifFull-year 2026 organic revenue growth lands at 7% to 9% or higher in constant currency.
Worry ifFull-year organic growth falls below 7% in constant currency, or Waters cuts the range.
Why it matters: Waters set this range after Q2 organic growth reached 9% in constant currency. Meeting it would support its higher full-year growth view.
Supportive ifQ3 organic revenue growth is 8% to 10% in constant currency, as guided.
Worry ifQ3 organic revenue growth is below 8% in constant currency.
Why it matters: Waters raised its EPS range after two quarters of strong results. Meeting it would support the company's higher profit view.
Supportive ifFull-year 2026 adjusted EPS is $14.45 to $14.65, or above the range.
Worry ifAdjusted EPS falls below $14.45, or Waters cuts its guidance range.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$107 on $10,000 · ±1.1% | How much price usually moves either way. |
| Bad day | $295 loss on $10,000 · 2.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,132 loss on $10,000 · 31.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.